FDA NDC Directory · JSON-LD · Markdown

Xofluza

NDC 50242-617 · HUMAN PRESCRIPTION DRUG · GRANULE, FOR SUSPENSION

Generic nameBaloxavir Marboxil
Labeler / ManufacturerGenentech, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214410
Dosage form / routeGRANULE, FOR SUSPENSION · ORAL
Active ingredientsBALOXAVIR MARBOXIL (40 mg/1)
Marketing started20250530
Package count1

External sources

Source: openFDA. Public-domain (CC0).